INS and hyperlipidemia: Increased free radical formation and compromised antioxidant defense systems have been implicated in the development of diabetic neuropathy [7,8], but more complex pathophysiological pathways, such as hyperglycemia, hyperlipidemia and impaired insulin signaling, are also likely to be involved (Figure 2).